Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OABI
OABI logo

OABI News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

OABI News

OmniAb Reports Strong Q1 2026 Performance, Raises Revenue Guidance

3d agoseekingalpha

OmniAb (OABI) Q4 2025 Earnings Call Transcript

Mar 15 2026NASDAQ.COM

OmniAb Q4 2025 Earnings Call Highlights

Mar 15 2026Yahoo Finance

OmniAb Reports Q4 2025 Earnings with Growth Momentum

Mar 05 2026seekingalpha

OmniAb Reports Q4 Earnings Miss with Revenue Decline

Mar 04 2026seekingalpha

OmniAb Launches First Transgenic Chicken Platform, Expanding Therapeutic Opportunities

Dec 15 2025Newsfilter

GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4

Dec 11 2025Newsfilter

GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 at 10μg/kg/day

Dec 11 2025PRnewswire

OABI Events

05/07 17:10
OmniAb Reports Q1 Revenue of $14.4M, Exceeding Expectations
Reports Q1 revenue $14.4M, consensus $5.6M. "OmniAb experienced strong momentum during the first quarter as multiple partnered programs advanced into later-stage clinical development, reinforcing the diversity and value of our portfolio. With a very strong start to the year, we are raising our 2026 revenue guidance," stated Matt Foehr, Chief Executive Officer of OmniAb. "Continued progression of partner programs highlights the value of our technology platform and positions our business well for the future. Our innovation efforts continue to differentiate our platform as demonstrated by the launch of OmniUltra(TM) and our xPloration(R) partner access program."
05/07 17:10
OmniAb Raises 2026 Revenue Guidance to $28M-$33M
OmniAb revises 2026 financial guidance and now expects revenue to be in the range of $28 million to $33 million, versus $25 million to $30 million previously, and costs and operating expenses to be in the range of $83 million to $88 million, versus $80 million to $85 million previously. Cash costs and operating expenses remain unchanged and are expected to be in the range of $50 million to $55 million (see note regarding "Use of Non-GAAP Financial Measure" below for further discussion of this non-GAAP measure). The Company now expects to end the year with cash and cash equivalents in the range of $33 million to $38 million, versus $30 million to $35 million previously. The full-year 2026 effective tax rate is expected to be approximately 0%.
03/04 16:20
OmniAb Q4 Revenue at $8.4M, Below Consensus
Reports Q4 revenue $8.4M, consensus $9.0M. "OmniAb exited 2025 with an expanded base of 107 active partners and a growing portfolio of 407 active programs. Our differentiated technologies support our business outlook and allow us to add programs while maintaining a disciplined cost structure. As our partner pipeline continues to advance, several later-stage assets are emerging with potential to generate meaningful milestones and, ultimately, recurring royalty revenue," said Matt Foehr, Chief Executive Officer of OmniAb. "Our focus on innovation was evident in the recent launch of OmniUltra(TM), which strengthens our ability to attract new partners and service new programs. Additionally, we continue to see strong interest in the xPloration partner access program and are excited about its contributions to the business."
03/04 16:20
OmniAb Expects 2026 Revenue of $25M to $30M
OmniAb expects 2026 revenue to be in the range of $25 million to $30 million, and costs and operating expenses to be in the range of $80 million to $85 million. Cash costs and operating expenses is expected to be in the range of $50 million to $55 million.

OABI Monitor News

No data

No data

OABI Earnings Analysis

No Data

No Data

People Also Watch